Your browser doesn't support javascript.
loading
Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera.
Gisslinger, Heinz; Zagrijtschuk, Oleh; Buxhofer-Ausch, Veronika; Thaler, Josef; Schloegl, Ernst; Gastl, Guenther A; Wolf, Dominik; Kralovics, Robert; Gisslinger, Bettina; Strecker, Karin; Egle, Alexander; Melchardt, Thomas; Burgstaller, Sonja; Willenbacher, Ella; Schalling, Martin; Them, Nicole C; Kadlecova, Pavla; Klade, Christoph; Greil, Richard.
Afiliación
  • Gisslinger H; Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria;
  • Zagrijtschuk O; AOP Orphan Pharmaceuticals AG, Vienna, Austria;
  • Buxhofer-Ausch V; Sozialmedizinisches Zentrum Ost - Donauspital, Vienna, Austria; Krankenhaus der Elisabethinen Linz, Linz, Austria;
  • Thaler J; Department of Internal Medicine IV, Wels-Grieskirchen Hospital, Wels, Austria;
  • Schloegl E; Third Medical Department, Hanusch Hospital, Vienna, Austria;
  • Gastl GA; Department of Internal Medicine V, Hematology & Oncology, Innsbruck Medical University, Innsbruck, Austria;
  • Wolf D; Department of Internal Medicine V, Hematology & Oncology, Innsbruck Medical University, Innsbruck, Austria; Medical Clinic 3, Oncology, Hematology and Rheumatology, University Hospital of Bonn, Bonn, Germany;
  • Kralovics R; Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria; Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria;
  • Gisslinger B; Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria;
  • Strecker K; Sozialmedizinisches Zentrum Ost - Donauspital, Vienna, Austria;
  • Egle A; Laboratory for Immunological and Molecular Cancer Research, Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases, Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria; and.
  • Melchardt T; Laboratory for Immunological and Molecular Cancer Research, Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases, Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria; and.
  • Burgstaller S; Department of Internal Medicine IV, Wels-Grieskirchen Hospital, Wels, Austria;
  • Willenbacher E; Department of Internal Medicine V, Hematology & Oncology, Innsbruck Medical University, Innsbruck, Austria;
  • Schalling M; Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria;
  • Them NC; Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria;
  • Kadlecova P; Advanced Drug and Device Services SAS, Brno, Czech Republic.
  • Klade C; AOP Orphan Pharmaceuticals AG, Vienna, Austria;
  • Greil R; Laboratory for Immunological and Molecular Cancer Research, Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases, Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria; and.
Blood ; 126(15): 1762-9, 2015 Oct 08.
Article en En | MEDLINE | ID: mdl-26261238

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Policitemia Vera / Polietilenglicoles / Proteínas Recombinantes / Interferón-alfa Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2015 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Policitemia Vera / Polietilenglicoles / Proteínas Recombinantes / Interferón-alfa Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2015 Tipo del documento: Article